The global market for Microfluidic in Vitro Diagnostics was valued at US$ 8124 million in the year 2024 and is projected to reach a revised size of US$ 19465 million by 2031, growing at a CAGR of 13.2% during the forecast period.

Microfluidic in Vitro Diagnostics Market

Microfluidic in vitro diagnostics (microfluidic IVD) integrates microscale fluid manipulation with molecular and biochemical detection methods to create lab-on-a-chip or single-use cartridge solutions for rapid processing and testing of biological samples such as blood, saliva, and swabs. By combining microchannels, micropumps, microvalves and integrated sensing units, microfluidic IVD achieves high integration and automation, significantly shortening workflows while improving sensitivity and reproducibility. These systems can deliver end-to-end sample preparation and result readout across clinical laboratories, primary care and point-of-care settings, offering portability with scalable throughput. With advances in automated manufacturing, reagent lyophilization and digital data platforms, microfluidic IVD is positioned as a core technology to enable diagnostic decentralization, strengthen public-health responsiveness, and support personalized testing strategies.

Microfluidic IVD is poised at an industrial inflection point. Major diagnostics companies emphasize “faster, smaller, smarter” strategies in their annual reports, pushing technologies from centralized labs toward point-of-care scenarios and creating a commercialization window for microfluidic solutions. At the same time, regulators’ increasing focus on POCT and novel IVDs, along with modernized approval pathways, provides policy space for clinical adoption and market rollout. Capital markets and M&A are also targeting companies that can deliver “chip-based + digital” integrated solutions, which unlocks R&D resources and accelerates ecosystem aggregation. For firms seeking differentiated, high-value offerings, microfluidics represents both a technical moat and an accelerator for commercialization.

Despite clear opportunities, commercialization is challenging. Key issues stem from manufacturing and quality control: from microstructure fabrication to batch consistency and stable reagent integration, every step demands stringent engineering and scale-up capability. Regulatory and clinical validation uncertainties can prolong time-to-market and increase upfront capital needs. Geopolitical and procurement policy shifts also make supply-chain resilience a critical competitive factor; companies overly dependent on imported materials or equipment may face forced adjustments. Firms must find a pragmatic balance between innovation speed and regulatory cadence to avoid leading technically but lagging commercially.

Downstream demand is evolving from “result-centric” to “scenario- and connectivity-centric.” Hospitals and clinical labs maintain rigid requirements for accuracy and reproducibility, while community care, corporate testing and at-home health management increasingly prioritize portability, cost and immediate feedback. Pharma and biotech companies’ willingness to collaborate on companion diagnostics and rapid screening creates pathways for microfluidic platforms to move into higher-value healthcare services. For marketing and BD teams, positioning microfluidic products as “clinically trusted point-of-care solutions” with seamless digital integration will be a persuasive narrative for both procurement decision-makers and investors.

The microfluidic upstream ecosystem centers on materials, precision manufacturing, and surface chemistry. High-performance polymers and functional coatings determine chip processability and biocompatibility; glass and silicon remain indispensable for high-end optical and thermal applications; and specialized reagents for surface modification and biomolecule immobilization directly affect assay sensitivity and specificity. Annual reports and regulatory documents indicate that as countries promote localized medical device supply chains, regionalization of materials and manufacturing becomes increasingly important. Firms that control key upstream materials and processes will be better positioned on price, delivery and compliance, creating durable competitive barriers.

This report aims to provide a comprehensive presentation of the global market for Microfluidic in Vitro Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microfluidic in Vitro Diagnostics.

The Microfluidic in Vitro Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Microfluidic in Vitro Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Microfluidic in Vitro Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Microfluidic in Vitro Diagnostics Market Report

Report Metric	Details
Report Name	Microfluidic in Vitro Diagnostics Market
Accounted market size in year	US$ 8124 million
Forecasted market size in 2031	US$ 19465 million
CAGR	13.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Biochemical Diagnosis Molecular Diagnosis POCT Other
Segment by Application	Hospital Third-party Laboratory Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Danaher (Cephi), Roche, Abbott, bioMérieux, Hologic, Thermo Fisher Scientific, Revitty, Agilent Technologies, Bio-Rad Laboratories, Illumina, Bohui-TECH, Bio-Biotech, Sinxiang Biotech, Kayoudi, Hangzhou Ustar
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Microfluidic in Vitro Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Microfluidic in Vitro Diagnostics Market growing?

Ans: The Microfluidic in Vitro Diagnostics Market witnessing a CAGR of 13.2% during the forecast period 2025-2031.

What is the Microfluidic in Vitro Diagnostics Market size in 2031?

Ans: The Microfluidic in Vitro Diagnostics Market size in 2031 will be US$ 19465 million.

Who are the main players in the Microfluidic in Vitro Diagnostics Market report?

Ans: The main players in the Microfluidic in Vitro Diagnostics Market are Danaher (Cephi), Roche, Abbott, bioMérieux, Hologic, Thermo Fisher Scientific, Revitty, Agilent Technologies, Bio-Rad Laboratories, Illumina, Bohui-TECH, Bio-Biotech, Sinxiang Biotech, Kayoudi, Hangzhou Ustar

What are the Application segmentation covered in the Microfluidic in Vitro Diagnostics Market report?

Ans: The Applications covered in the Microfluidic in Vitro Diagnostics Market report are Hospital, Third-party Laboratory, Other

What are the Type segmentation covered in the Microfluidic in Vitro Diagnostics Market report?

Ans: The Types covered in the Microfluidic in Vitro Diagnostics Market report are Biochemical Diagnosis, Molecular Diagnosis, POCT, Other

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Microfluidic in Vitro Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Biochemical Diagnosis

1.2.3 Molecular Diagnosis

1.2.4 POCT

1.2.5 Other

1.3 Market by Application

1.3.1 Global Microfluidic in Vitro Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Third-party Laboratory

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Microfluidic in Vitro Diagnostics Market Perspective (2020-2031)

2.2 Global Microfluidic in Vitro Diagnostics Growth Trends by Region

2.2.1 Global Microfluidic in Vitro Diagnostics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Microfluidic in Vitro Diagnostics Historic Market Size by Region (2020-2025)

2.2.3 Microfluidic in Vitro Diagnostics Forecasted Market Size by Region (2026-2031)

2.3 Microfluidic in Vitro Diagnostics Market Dynamics

2.3.1 Microfluidic in Vitro Diagnostics Industry Trends

2.3.2 Microfluidic in Vitro Diagnostics Market Drivers

2.3.3 Microfluidic in Vitro Diagnostics Market Challenges

2.3.4 Microfluidic in Vitro Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Microfluidic in Vitro Diagnostics Players by Revenue

3.1.1 Global Top Microfluidic in Vitro Diagnostics Players by Revenue (2020-2025)

3.1.2 Global Microfluidic in Vitro Diagnostics Revenue Market Share by Players (2020-2025)

3.2 Global Top Microfluidic in Vitro Diagnostics Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Microfluidic in Vitro Diagnostics Revenue

3.4 Global Microfluidic in Vitro Diagnostics Market Concentration Ratio

3.4.1 Global Microfluidic in Vitro Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Microfluidic in Vitro Diagnostics Revenue in 2024

3.5 Global Key Players of Microfluidic in Vitro Diagnostics Head office and Area Served

3.6 Global Key Players of Microfluidic in Vitro Diagnostics, Product and Application

3.7 Global Key Players of Microfluidic in Vitro Diagnostics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Microfluidic in Vitro Diagnostics Breakdown Data by Type

4.1 Global Microfluidic in Vitro Diagnostics Historic Market Size by Type (2020-2025)

4.2 Global Microfluidic in Vitro Diagnostics Forecasted Market Size by Type (2026-2031)

5 Microfluidic in Vitro Diagnostics Breakdown Data by Application

5.1 Global Microfluidic in Vitro Diagnostics Historic Market Size by Application (2020-2025)

5.2 Global Microfluidic in Vitro Diagnostics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Microfluidic in Vitro Diagnostics Market Size (2020-2031)

6.2 North America Microfluidic in Vitro Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Microfluidic in Vitro Diagnostics Market Size by Country (2020-2025)

6.4 North America Microfluidic in Vitro Diagnostics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Microfluidic in Vitro Diagnostics Market Size (2020-2031)

7.2 Europe Microfluidic in Vitro Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Microfluidic in Vitro Diagnostics Market Size by Country (2020-2025)

7.4 Europe Microfluidic in Vitro Diagnostics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Microfluidic in Vitro Diagnostics Market Size (2020-2031)

8.2 Asia-Pacific Microfluidic in Vitro Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Microfluidic in Vitro Diagnostics Market Size by Region (2020-2025)

8.4 Asia-Pacific Microfluidic in Vitro Diagnostics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Microfluidic in Vitro Diagnostics Market Size (2020-2031)

9.2 Latin America Microfluidic in Vitro Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Microfluidic in Vitro Diagnostics Market Size by Country (2020-2025)

9.4 Latin America Microfluidic in Vitro Diagnostics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Microfluidic in Vitro Diagnostics Market Size (2020-2031)

10.2 Middle East & Africa Microfluidic in Vitro Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Microfluidic in Vitro Diagnostics Market Size by Country (2020-2025)

10.4 Middle East & Africa Microfluidic in Vitro Diagnostics Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Danaher (Cephi)

11.1.1 Danaher (Cephi) Company Details

11.1.2 Danaher (Cephi) Business Overview

11.1.3 Danaher (Cephi) Microfluidic in Vitro Diagnostics Introduction

11.1.4 Danaher (Cephi) Revenue in Microfluidic in Vitro Diagnostics Business (2020-2025)

11.1.5 Danaher (Cephi) Recent Development

11.2 Roche

11.2.1 Roche Company Details

11.2.2 Roche Business Overview

11.2.3 Roche Microfluidic in Vitro Diagnostics Introduction

11.2.4 Roche Revenue in Microfluidic in Vitro Diagnostics Business (2020-2025)

11.2.5 Roche Recent Development

11.3 Abbott

11.3.1 Abbott Company Details

11.3.2 Abbott Business Overview

11.3.3 Abbott Microfluidic in Vitro Diagnostics Introduction

11.3.4 Abbott Revenue in Microfluidic in Vitro Diagnostics Business (2020-2025)

11.3.5 Abbott Recent Development

11.4 bioMérieux

11.4.1 bioMérieux Company Details

11.4.2 bioMérieux Business Overview

11.4.3 bioMérieux Microfluidic in Vitro Diagnostics Introduction

11.4.4 bioMérieux Revenue in Microfluidic in Vitro Diagnostics Business (2020-2025)

11.4.5 bioMérieux Recent Development

11.5 Hologic

11.5.1 Hologic Company Details

11.5.2 Hologic Business Overview

11.5.3 Hologic Microfluidic in Vitro Diagnostics Introduction

11.5.4 Hologic Revenue in Microfluidic in Vitro Diagnostics Business (2020-2025)

11.5.5 Hologic Recent Development

11.6 Thermo Fisher Scientific

11.6.1 Thermo Fisher Scientific Company Details

11.6.2 Thermo Fisher Scientific Business Overview

11.6.3 Thermo Fisher Scientific Microfluidic in Vitro Diagnostics Introduction

11.6.4 Thermo Fisher Scientific Revenue in Microfluidic in Vitro Diagnostics Business (2020-2025)

11.6.5 Thermo Fisher Scientific Recent Development

11.7 Revitty

11.7.1 Revitty Company Details

11.7.2 Revitty Business Overview

11.7.3 Revitty Microfluidic in Vitro Diagnostics Introduction

11.7.4 Revitty Revenue in Microfluidic in Vitro Diagnostics Business (2020-2025)

11.7.5 Revitty Recent Development

11.8 Agilent Technologies

11.8.1 Agilent Technologies Company Details

11.8.2 Agilent Technologies Business Overview

11.8.3 Agilent Technologies Microfluidic in Vitro Diagnostics Introduction

11.8.4 Agilent Technologies Revenue in Microfluidic in Vitro Diagnostics Business (2020-2025)

11.8.5 Agilent Technologies Recent Development

11.9 Bio-Rad Laboratories

11.9.1 Bio-Rad Laboratories Company Details

11.9.2 Bio-Rad Laboratories Business Overview

11.9.3 Bio-Rad Laboratories Microfluidic in Vitro Diagnostics Introduction

11.9.4 Bio-Rad Laboratories Revenue in Microfluidic in Vitro Diagnostics Business (2020-2025)

11.9.5 Bio-Rad Laboratories Recent Development

11.10 Illumina

11.10.1 Illumina Company Details

11.10.2 Illumina Business Overview

11.10.3 Illumina Microfluidic in Vitro Diagnostics Introduction

11.10.4 Illumina Revenue in Microfluidic in Vitro Diagnostics Business (2020-2025)

11.10.5 Illumina Recent Development

11.11 Bohui-TECH

11.11.1 Bohui-TECH Company Details

11.11.2 Bohui-TECH Business Overview

11.11.3 Bohui-TECH Microfluidic in Vitro Diagnostics Introduction

11.11.4 Bohui-TECH Revenue in Microfluidic in Vitro Diagnostics Business (2020-2025)

11.11.5 Bohui-TECH Recent Development

11.12 Bio-Biotech

11.12.1 Bio-Biotech Company Details

11.12.2 Bio-Biotech Business Overview

11.12.3 Bio-Biotech Microfluidic in Vitro Diagnostics Introduction

11.12.4 Bio-Biotech Revenue in Microfluidic in Vitro Diagnostics Business (2020-2025)

11.12.5 Bio-Biotech Recent Development

11.13 Sinxiang Biotech

11.13.1 Sinxiang Biotech Company Details

11.13.2 Sinxiang Biotech Business Overview

11.13.3 Sinxiang Biotech Microfluidic in Vitro Diagnostics Introduction

11.13.4 Sinxiang Biotech Revenue in Microfluidic in Vitro Diagnostics Business (2020-2025)

11.13.5 Sinxiang Biotech Recent Development

11.14 Kayoudi

11.14.1 Kayoudi Company Details

11.14.2 Kayoudi Business Overview

11.14.3 Kayoudi Microfluidic in Vitro Diagnostics Introduction

11.14.4 Kayoudi Revenue in Microfluidic in Vitro Diagnostics Business (2020-2025)

11.14.5 Kayoudi Recent Development

11.15 Hangzhou Ustar

11.15.1 Hangzhou Ustar Company Details

11.15.2 Hangzhou Ustar Business Overview

11.15.3 Hangzhou Ustar Microfluidic in Vitro Diagnostics Introduction

11.15.4 Hangzhou Ustar Revenue in Microfluidic in Vitro Diagnostics Business (2020-2025)

11.15.5 Hangzhou Ustar Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Thermo Fisher Scientific

List of Tables

Table 1. Global Microfluidic in Vitro Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Biochemical Diagnosis

Table 3. Key Players of Molecular Diagnosis

Table 4. Key Players of POCT

Table 5. Key Players of Other

Table 6. Global Microfluidic in Vitro Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Microfluidic in Vitro Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Microfluidic in Vitro Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Microfluidic in Vitro Diagnostics Market Share by Region (2020-2025)

Table 10. Global Microfluidic in Vitro Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Microfluidic in Vitro Diagnostics Market Share by Region (2026-2031)

Table 12. Microfluidic in Vitro Diagnostics Market Trends

Table 13. Microfluidic in Vitro Diagnostics Market Drivers

Table 14. Microfluidic in Vitro Diagnostics Market Challenges

Table 15. Microfluidic in Vitro Diagnostics Market Restraints

Table 16. Global Microfluidic in Vitro Diagnostics Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Microfluidic in Vitro Diagnostics Market Share by Players (2020-2025)

Table 18. Global Top Microfluidic in Vitro Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microfluidic in Vitro Diagnostics as of 2024)

Table 19. Ranking of Global Top Microfluidic in Vitro Diagnostics Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Microfluidic in Vitro Diagnostics Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Microfluidic in Vitro Diagnostics, Headquarters and Area Served

Table 22. Global Key Players of Microfluidic in Vitro Diagnostics, Product and Application

Table 23. Global Key Players of Microfluidic in Vitro Diagnostics, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Microfluidic in Vitro Diagnostics Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Microfluidic in Vitro Diagnostics Revenue Market Share by Type (2020-2025)

Table 27. Global Microfluidic in Vitro Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Microfluidic in Vitro Diagnostics Revenue Market Share by Type (2026-2031)

Table 29. Global Microfluidic in Vitro Diagnostics Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Microfluidic in Vitro Diagnostics Revenue Market Share by Application (2020-2025)

Table 31. Global Microfluidic in Vitro Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Microfluidic in Vitro Diagnostics Revenue Market Share by Application (2026-2031)

Table 33. North America Microfluidic in Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Microfluidic in Vitro Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Microfluidic in Vitro Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Microfluidic in Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Microfluidic in Vitro Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Microfluidic in Vitro Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Microfluidic in Vitro Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Microfluidic in Vitro Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Microfluidic in Vitro Diagnostics Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Microfluidic in Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Microfluidic in Vitro Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Microfluidic in Vitro Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Microfluidic in Vitro Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Microfluidic in Vitro Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Microfluidic in Vitro Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 48. Danaher (Cephi) Company Details

Table 49. Danaher (Cephi) Business Overview

Table 50. Danaher (Cephi) Microfluidic in Vitro Diagnostics Product

Table 51. Danaher (Cephi) Revenue in Microfluidic in Vitro Diagnostics Business (2020-2025) & (US$ Million)

Table 52. Danaher (Cephi) Recent Development

Table 53. Roche Company Details

Table 54. Roche Business Overview

Table 55. Roche Microfluidic in Vitro Diagnostics Product

Table 56. Roche Revenue in Microfluidic in Vitro Diagnostics Business (2020-2025) & (US$ Million)

Table 57. Roche Recent Development

Table 58. Abbott Company Details

Table 59. Abbott Business Overview

Table 60. Abbott Microfluidic in Vitro Diagnostics Product

Table 61. Abbott Revenue in Microfluidic in Vitro Diagnostics Business (2020-2025) & (US$ Million)

Table 62. Abbott Recent Development

Table 63. bioMérieux Company Details

Table 64. bioMérieux Business Overview

Table 65. bioMérieux Microfluidic in Vitro Diagnostics Product

Table 66. bioMérieux Revenue in Microfluidic in Vitro Diagnostics Business (2020-2025) & (US$ Million)

Table 67. bioMérieux Recent Development

Table 68. Hologic Company Details

Table 69. Hologic Business Overview

Table 70. Hologic Microfluidic in Vitro Diagnostics Product

Table 71. Hologic Revenue in Microfluidic in Vitro Diagnostics Business (2020-2025) & (US$ Million)

Table 72. Hologic Recent Development

Table 73. Thermo Fisher Scientific Company Details

Table 74. Thermo Fisher Scientific Business Overview

Table 75. Thermo Fisher Scientific Microfluidic in Vitro Diagnostics Product

Table 76. Thermo Fisher Scientific Revenue in Microfluidic in Vitro Diagnostics Business (2020-2025) & (US$ Million)

Table 77. Thermo Fisher Scientific Recent Development

Table 78. Revitty Company Details

Table 79. Revitty Business Overview

Table 80. Revitty Microfluidic in Vitro Diagnostics Product

Table 81. Revitty Revenue in Microfluidic in Vitro Diagnostics Business (2020-2025) & (US$ Million)

Table 82. Revitty Recent Development

Table 83. Agilent Technologies Company Details

Table 84. Agilent Technologies Business Overview

Table 85. Agilent Technologies Microfluidic in Vitro Diagnostics Product

Table 86. Agilent Technologies Revenue in Microfluidic in Vitro Diagnostics Business (2020-2025) & (US$ Million)

Table 87. Agilent Technologies Recent Development

Table 88. Bio-Rad Laboratories Company Details

Table 89. Bio-Rad Laboratories Business Overview

Table 90. Bio-Rad Laboratories Microfluidic in Vitro Diagnostics Product

Table 91. Bio-Rad Laboratories Revenue in Microfluidic in Vitro Diagnostics Business (2020-2025) & (US$ Million)

Table 92. Bio-Rad Laboratories Recent Development

Table 93. Illumina Company Details

Table 94. Illumina Business Overview

Table 95. Illumina Microfluidic in Vitro Diagnostics Product

Table 96. Illumina Revenue in Microfluidic in Vitro Diagnostics Business (2020-2025) & (US$ Million)

Table 97. Illumina Recent Development

Table 98. Bohui-TECH Company Details

Table 99. Bohui-TECH Business Overview

Table 100. Bohui-TECH Microfluidic in Vitro Diagnostics Product

Table 101. Bohui-TECH Revenue in Microfluidic in Vitro Diagnostics Business (2020-2025) & (US$ Million)

Table 102. Bohui-TECH Recent Development

Table 103. Bio-Biotech Company Details

Table 104. Bio-Biotech Business Overview

Table 105. Bio-Biotech Microfluidic in Vitro Diagnostics Product

Table 106. Bio-Biotech Revenue in Microfluidic in Vitro Diagnostics Business (2020-2025) & (US$ Million)

Table 107. Bio-Biotech Recent Development

Table 108. Sinxiang Biotech Company Details

Table 109. Sinxiang Biotech Business Overview

Table 110. Sinxiang Biotech Microfluidic in Vitro Diagnostics Product

Table 111. Sinxiang Biotech Revenue in Microfluidic in Vitro Diagnostics Business (2020-2025) & (US$ Million)

Table 112. Sinxiang Biotech Recent Development

Table 113. Kayoudi Company Details

Table 114. Kayoudi Business Overview

Table 115. Kayoudi Microfluidic in Vitro Diagnostics Product

Table 116. Kayoudi Revenue in Microfluidic in Vitro Diagnostics Business (2020-2025) & (US$ Million)

Table 117. Kayoudi Recent Development

Table 118. Hangzhou Ustar Company Details

Table 119. Hangzhou Ustar Business Overview

Table 120. Hangzhou Ustar Microfluidic in Vitro Diagnostics Product

Table 121. Hangzhou Ustar Revenue in Microfluidic in Vitro Diagnostics Business (2020-2025) & (US$ Million)

Table 122. Hangzhou Ustar Recent Development

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Microfluidic in Vitro Diagnostics Picture

Figure 2. Global Microfluidic in Vitro Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Microfluidic in Vitro Diagnostics Market Share by Type: 2024 VS 2031

Figure 4. Biochemical Diagnosis Features

Figure 5. Molecular Diagnosis Features

Figure 6. POCT Features

Figure 7. Other Features

Figure 8. Global Microfluidic in Vitro Diagnostics Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Microfluidic in Vitro Diagnostics Market Share by Application: 2024 VS 2031

Figure 10. Hospital Case Studies

Figure 11. Third-party Laboratory Case Studies

Figure 12. Other Case Studies

Figure 13. Microfluidic in Vitro Diagnostics Report Years Considered

Figure 14. Global Microfluidic in Vitro Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Microfluidic in Vitro Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Microfluidic in Vitro Diagnostics Market Share by Region: 2024 VS 2031

Figure 17. Global Microfluidic in Vitro Diagnostics Market Share by Players in 2024

Figure 18. Global Microfluidic in Vitro Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 19. The Top 10 and 5 Players Market Share by Microfluidic in Vitro Diagnostics Revenue in 2024

Figure 20. North America Microfluidic in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Microfluidic in Vitro Diagnostics Market Share by Country (2020-2031)

Figure 22. United States Microfluidic in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Microfluidic in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Microfluidic in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Microfluidic in Vitro Diagnostics Market Share by Country (2020-2031)

Figure 26. Germany Microfluidic in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Microfluidic in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Microfluidic in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Microfluidic in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Microfluidic in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Ireland Microfluidic in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Microfluidic in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Microfluidic in Vitro Diagnostics Market Share by Region (2020-2031)

Figure 34. China Microfluidic in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Microfluidic in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Microfluidic in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Microfluidic in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Microfluidic in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia & New Zealand Microfluidic in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Microfluidic in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Microfluidic in Vitro Diagnostics Market Share by Country (2020-2031)

Figure 42. Mexico Microfluidic in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Microfluidic in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Microfluidic in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Microfluidic in Vitro Diagnostics Market Share by Country (2020-2031)

Figure 46. Israel Microfluidic in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Microfluidic in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Microfluidic in Vitro Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Danaher (Cephi) Revenue Growth Rate in Microfluidic in Vitro Diagnostics Business (2020-2025)

Figure 50. Roche Revenue Growth Rate in Microfluidic in Vitro Diagnostics Business (2020-2025)

Figure 51. Abbott Revenue Growth Rate in Microfluidic in Vitro Diagnostics Business (2020-2025)

Figure 52. bioMérieux Revenue Growth Rate in Microfluidic in Vitro Diagnostics Business (2020-2025)

Figure 53. Hologic Revenue Growth Rate in Microfluidic in Vitro Diagnostics Business (2020-2025)

Figure 54. Thermo Fisher Scientific Revenue Growth Rate in Microfluidic in Vitro Diagnostics Business (2020-2025)

Figure 55. Revitty Revenue Growth Rate in Microfluidic in Vitro Diagnostics Business (2020-2025)

Figure 56. Agilent Technologies Revenue Growth Rate in Microfluidic in Vitro Diagnostics Business (2020-2025)

Figure 57. Bio-Rad Laboratories Revenue Growth Rate in Microfluidic in Vitro Diagnostics Business (2020-2025)

Figure 58. Illumina Revenue Growth Rate in Microfluidic in Vitro Diagnostics Business (2020-2025)

Figure 59. Bohui-TECH Revenue Growth Rate in Microfluidic in Vitro Diagnostics Business (2020-2025)

Figure 60. Bio-Biotech Revenue Growth Rate in Microfluidic in Vitro Diagnostics Business (2020-2025)

Figure 61. Sinxiang Biotech Revenue Growth Rate in Microfluidic in Vitro Diagnostics Business (2020-2025)

Figure 62. Kayoudi Revenue Growth Rate in Microfluidic in Vitro Diagnostics Business (2020-2025)

Figure 63. Hangzhou Ustar Revenue Growth Rate in Microfluidic in Vitro Diagnostics Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Microfluidic in Vitro Diagnostics Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-24Z19487

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Yohimbe Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34B2983

Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Erection Rings Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19V3238

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Sperm Bank Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35F5845

Wed Sep 10 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions